Overexpression of SKP2 promotes the radiation resistance of esophageal squamous cell carcinoma

Radiation Research

Volumn 177, Issue 1, 2012, Pages 52-58

  Wang, Xiao Chun ^a   Tian, Li Li ^b   Tian, Jing ^c   Jiang, Xiao Yan ^d  

^a INSTITUTE OF RADIATION MEDICINE   (China)

^b Beijing Centers for Diseases Control and Prevention   (China)

^c Shandong Province Institute of Cancer Prevention and Treatment   (China)

^d CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; MUTANT PROTEIN; RAD51 PROTEIN; S PHASE KINASE ASSOCIATED PROTEIN 2; SMALL INTERFERING RNA; UBIQUITIN; UBIQUITIN PROTEIN LIGASE;

ARTICLE; CANCER CELL; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CONTROLLED STUDY; ENZYME DEGRADATION; ESOPHAGUS CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOSENSITIVITY; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DNA BREAKS, DOUBLE-STRANDED; DNA REPAIR; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PROGNOSIS; RAD51 RECOMBINASE; RADIATION TOLERANCE; S-PHASE KINASE-ASSOCIATED PROTEINS; SURVIVAL ANALYSIS;

EID: 84255193994     PISSN: 00337587     EISSN: 19385404     Source Type: Journal    
DOI: 10.1667/RR2679.1     Document Type: Article

References (20)

1. Berger B, Belka C. Evidence-based radiation oncology: oesophagus. Radiother Oncol 2009; 92:276-90.
2. Borghesi S, Hawkins MA, Tait D. Oesophagectomy after definitive chemoradiation in patients with locally advanced oesophageal cancer. Clin Oncol (R Coll Radiol) 2008; 20:221-6.
3. Zhang H, Kobayashi R, Galaktionov K, Beach D. p19Skp1 and p45Skp2 are essential elements of the cyclin A-CDK2 S phase kinase. Cell 1995; 82:915-25.
4. Nakayama K, Nagahama H, Minamishima YA, Matsumoto M, Nakamichi I, Kitagawa K, et al. Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication. EMBO J 2000; 19:2069-81. (Pubitemid 30237582)
5. Sutterluty H, Chatelain E, Marti A, Wirbelauer C, Senften M, Muller U, et al. p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells. Nat Cell Biol 1999; 1:207-14. (Pubitemid 129500939)
6. Masuda TA, Inoue H, Sonoda H, Mine S, Yoshikawa Y, Nakayama K, et al. Clinical and biological significance of Sphase kinase-associated protein 2 (Skp2) gene expression in gastric carcinoma: modulation of malignant phenotype by Skp2 overexpression, possibly via p27 proteolysis. Cancer Res 2002; 62:3819-25. (Pubitemid 34728867)
7. Yokoi S, Yasui K, Saito-Ohara F, Koshikawa K, Iizasa T, Fujisawa T, et al. A novel target gene, SKP2, within the 5p13 amplicon that is frequently detected in small cell lung cancers. Am J Pathol 2002; 161:207-16. (Pubitemid 34760786)
8. Gstaiger M, Jordan R, Lim M, Catzavelos C, Mestan J, Slingerland J, et al. Skp2 is oncogenic and overexpressed in human cancers. Proc Natl Acad Sci U S A 2001; 98:5043-8. (Pubitemid 32397079)
9. Wang XC, Wu YP, Ye B, Lin DC, Feng YB, Zhang ZQ, et al. Suppression of anoikis by SKP2 amplification and overexpression promotes metastasis of esophageal squamous cell carcinoma. Mol Cancer Res 2009; 7:12-22.
10. Zhu CQ, Blackhall FH, Pintilie M, Iyengar P, Liiu N, Ho J, et al. Skp2 gene copy number aberrations are common in non-small cell lung carcinoma, and its overexpression in tumors with ras mutation is a poor prognostic marker. Clin Cancer Res 2004; 10:1984-91. (Pubitemid 38375557)
11. Kudo Y, Kitajima S, Sato S, Miyauchi M, Ogawa I, Takata T. High expression of S-phase kinase-interacting protein 2, human Fbox protein, correlates with poor prognosis in oral squamous cell carcinomas. Cancer Res 2001; 61:7044-7. (Pubitemid 32946493)
12. Kudo Y, Kitajima S, Ogawa I, Kitagawa M, Miyauchi M, Takata T. Small interfering RNA targeting of S phase kinase-interacting protein 2 inhibits cell growth of oral cancer cells by inhibiting p27 degradation. Mol Cancer Ther 2005; 4:471-6. (Pubitemid 40443932)
13. Shapira M, Ben-Izhak O, Linn S, Futerman B, Minkov I, Hershko DD. The prognostic impact of the ubiquitin ligase subunits Skp2 and Cks1 in colorectal carcinoma. Cancer 2005; 103:1336-46. (Pubitemid 40410727)
14. Chiarle R, Fan Y, Piva R, Boggino H, Skolnik J, Novero D, et al. S-phase kinase-associated protein 2 expression in non-Hodgkin's lymphoma inversely correlates with p27 expression and defines cells in S phase. Am J Pathol 2002; 160:1457-66. (Pubitemid 34411648)
15. Signoretti S, Di Marcotullio L, Richardson A, Ramaswamy S, Isaac B, Rue M, et al. Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer. J Clin Invest 2002; 110:633-41. (Pubitemid 34988787)
16. Yang G, Ayala G, De Marzo A, Tian W, Frolov A, Wheeler TM, et al. Elevated Skp2 protein expression in human prostate cancer: association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival. Clin Cancer Res 2002; 8:3419-26. (Pubitemid 35340716)
17. Fukuchi M, Masuda N, Nakajima M, Fukai Y, Miyazaki T, Kato H, et al. Inverse correlation between expression levels of p27 and the ubiquitin ligase subunit Skp2 in early esophageal squamous cell carcinoma. Anticancer Res 2004; 24:777-83. (Pubitemid 38625021)
18. Li Y, Tondravi M, Liu J, Smith E, Haudenschild CC, Kaczmarek M, et al. Cortactin potentiates bone metastasis of breast cancer cells. Cancer Res 2001; 61:6906-11. (Pubitemid 32896517)
19. Mladenov E, Iliakis G. Induction and repair of DNA double strand breaks: The increasing spectrum of non-homologous end joining pathways. Mutat Res 2011; 7:61-72.
20. Vispe S, Cazaux C, Lesca C, Defais M. Overexpression of Rad51 protein stimulates homologous recombination and increases resistance of mammalian cells to ionizing radiation. Nucleic Acids Res 1998; 26:2859-64. (Pubitemid 28297517)